Skip to content

To explore the effect of pain sensitivity questionnaire on intravenous analgesia after cesarean section

To explore the effect of pain sensitivity questionnaire on intravenous analgesia after cesarean section

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100051387
Enrollment
Unknown
Registered
2021-09-22
Start date
2021-09-27
Completion date
Unknown
Last updated
2022-06-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Management of postoperative analgesia

Interventions

Pain hypersensitivity observation group:The analgesic pump was prepared with 10 butorphanol tartrate (100µg /ml)
Pain hyposensitivity observation group:The analgesic pump was prepared with 14 butorphanol tartrate (140µg/mL)
Pain hypersensitivity control group:Analgesic pump prepared with 12 doses of Butorphanol tartrate (120µg/mL)
Pain hyposensitivity control group:Analgesic pump prepared with 12 doses of Butorphanol tartrate (120µg/mL)

Sponsors

The First Affiliated Hospital of Shihezi University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
22 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1.Cesarean section was performed with scar uterus as the indication; 2.ASA grade I or II; 3.Weight:50-80kg; 4.Height:150-170cm; 5.Aged 22 to 40 years; 6.The patient's coagulation system and blood routine were normal; 7.The patient was conscious and received postoperative patient-controlled intravenous analgesia cooperatively.

Exclusion criteria

Exclusion criteria: 1.Contraindications of intraspinal anesthesia; 2.Infection of puncture site; 3.Tumor; 4.Spinal deformity; 5.Preoperative sedation; 6.Neurological and psychiatric history; 7.Abnormal functions of heart, liver and kidney; 8.BMI>=30kg/m^2; 9.Regnant women with pregnancy induced hypertension; 10.Peripheral venous catheterization failed; 11.Intraoperative bleeding was more than 800 ml; 12.The operation time was more than 3 hours; 13.Incomplete data recording.

Design outcomes

Primary

MeasureTime frame
Pain sensitivity questionnaire;Blood pressure;Heart rate;Pain score;Ramsay score;Oxyhemoglobin saturation;Dosage of narcotic;Peroperative bleeding;Urine volume;Time of operation;Resting and motor visual simulation scores;Satisfaction rating;Postoperative adverse reaction;

Countries

China

Contacts

Public ContactDeng Chao

Shihezi University

xin20200202@126.com+86 13598781821

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026